At both Palmetto Health campuses, all prostate biopsies are reviewed
by two pathologists in order to improve tumor detection and ensure
concordance in Gleason scoring. State of the art immunohistochemistry
is available for the performance of ancillary markers.
To keep abreast of the latest medical research, our pathologists contribute to a
monthly multidisciplinary conference on Prostate disease, which is attended by
urologists, radiation oncologists, pathologists and medical oncologists from both
campuses, academicians from the school of medicine, and staff from the Palmetto
Health cancer registry. Additionally, our pathologists participate in a "blind"
reading of prostate biopsies from participants in the National Prostate cancer
prevention trial, which are correlated with a central/national pathology review.
PPS, PC pathologists come from diverse backgrounds and have
ample experience and expertise in Genitourinary pathology.
Intradepartmental consultation is actively encouraged, drawing on
the combined wealth of our diverse backgrounds in pathology.